261 related articles for article (PubMed ID: 21255656)
1. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
Yang J; Wadghiri YZ; Hoang DM; Tsui W; Sun Y; Chung E; Li Y; Wang A; de Leon M; Wisniewski T
Neuroimage; 2011 Apr; 55(4):1600-9. PubMed ID: 21255656
[TBL] [Abstract][Full Text] [Related]
2. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
[TBL] [Abstract][Full Text] [Related]
3. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging.
Ansciaux E; Burtea C; Laurent S; Crombez D; Nonclercq D; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2015; 10(3):211-24. PubMed ID: 25284012
[TBL] [Abstract][Full Text] [Related]
5. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
Sigurdsson EM; Wadghiri YZ; Mosconi L; Blind JA; Knudsen E; Asuni A; Scholtzova H; Tsui WH; Li Y; Sadowski M; Turnbull DH; de Leon MJ; Wisniewski T
Neurobiol Aging; 2008 Jun; 29(6):836-47. PubMed ID: 17291630
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques.
Kim JH; Ha TL; Im GH; Yang J; Seo SW; Chung JJ; Chae SY; Lee IS; Lee JH
Neuroreport; 2014 Mar; 25(4):211-8. PubMed ID: 24518227
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1-40 in a transgenic mouse model.
Kim JH; Ha TL; Im GH; Yang J; Seo SW; Lee IS; Lee JH
Neuroreport; 2013 Jan; 24(1):16-21. PubMed ID: 23168564
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
10. In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease.
Kim E; Di Censo D; Baraldo M; Simmons C; Rosa I; Randall K; Ballard C; Dickie BR; Williams SCR; Killick R; Cash D
Sci Rep; 2021 Jun; 11(1):12419. PubMed ID: 34127752
[TBL] [Abstract][Full Text] [Related]
11. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
[TBL] [Abstract][Full Text] [Related]
12. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.
André S; Ansciaux E; Saidi E; Larbanoix L; Stanicki D; Nonclercq D; Vander Elst L; Laurent S; Muller RN; Burtea C
J Alzheimers Dis; 2017; 60(4):1547-1565. PubMed ID: 29036827
[TBL] [Abstract][Full Text] [Related]
13. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
[TBL] [Abstract][Full Text] [Related]
14. Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging.
Ramakrishnan M; Wengenack TM; Kandimalla KK; Curran GL; Gilles EJ; Ramirez-Alvarado M; Lin J; Garwood M; Jack CR; Poduslo JF
Pharm Res; 2008 Aug; 25(8):1861-72. PubMed ID: 18443900
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
[TBL] [Abstract][Full Text] [Related]
16. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
17. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.
Meadowcroft MD; Connor JR; Smith MB; Yang QX
J Magn Reson Imaging; 2009 May; 29(5):997-1007. PubMed ID: 19388095
[TBL] [Abstract][Full Text] [Related]
18. Detecting amyloid-β plaques in Alzheimer's disease.
Baltes C; Princz-Kranz F; Rudin M; Mueggler T
Methods Mol Biol; 2011; 711():511-33. PubMed ID: 21279620
[TBL] [Abstract][Full Text] [Related]
19. Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer's disease transgenic mice.
Bigot C; Vanhoutte G; Verhoye M; Van der Linden A
Neuroimage; 2014 Feb; 87():111-9. PubMed ID: 24188815
[TBL] [Abstract][Full Text] [Related]
20. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
